Results 91 to 100 of about 32,071 (158)

Successful management of remdesivir extravasation [PDF]

Revista Española de Quimioterapia, 2022
Conde Estévez, David, Barrantes-González, Melisa, Cotrina Soliz, Maria Renne, Grau Cerrato, Santiago   +3 more
openaire   +3 more sources

Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven

Contemporary Clinical Trials Communications, 2020
From December 2019 to May 22, 2020 the emerging and ever-increasing pandemic of coronavirus 19 (COVID-19) had no effective and safe treatment. Not surprisingly, remdesivir attracted worldwide attention. In a trial published online ahead of print, of 1063
Richard D. Shih, Dennis G. Maki, Charles H. Hennekens   +2 more
doaj  

Remdesivir

Reactions Weekly, 2022
  +4 more sources

Remdesivir in Children

Pediatric Infectious Disease, 2021
openaire   +2 more sources

Hints of hope with remdesivir [PDF]

Nature Reviews Drug Discovery, 2020
openaire   +2 more sources

Remdesivir: Remedy the world is waiting for?

Medical Journal Armed Forces India, 2020
Suranagi, Umesh Devappa, Rehan, Harmeet Singh   +1 more
openaire   +2 more sources

Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study

Journal of Comparative Effectiveness Research
Aim: This observational study investigated the association between remdesivir treatment during hospitalization for COVID-19 and 30-day COVID-19-related and all-cause readmission across different variants time periods.
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Andre C Kalil, Vishnudas Sarda, Celine Der-Torossian, Thomas Oppelt, Mark Berry, Alpesh N Amin   +9 more
doaj   +1 more source

Remdesivir inhibits endothelial activation and atherosclerosis by coupling TAL1 to TRAF6. [PDF]

J Transl Med
Zhang H, Li R, Huo Q, Li L, Li M, Hu S, Ren C, Wu Z, Zhang C.   +8 more
europepmc   +1 more source

The impact of remdesivir on renal and liver functions in severe COVID-19 patients with presence of viral load. [PDF]

Sci Rep
Waldauf P, Jurisinova I, Svobodova E, Diblickova M, Tencer T, Zavora J, Smela G, Kupidlovska L, Adamkova V, Fridrichova M, Jerabkova K, Mikes J, Duska F, Dusek L, Balik M.   +14 more
europepmc   +1 more source

Assessing the effect of remdesivir alone and in combination with corticosteroids on time to death in COVID-19: A propensity score-matched analysis

Journal of Clinical Virology Plus
Background: This study aimed to evaluate the impact of remdesivir, alone or in combination with corticosteroids, on the time to death in COVID-19 patients. Methods: This retrospective cohort study was conducted between March 20, 2020, and March 18, 2021,
Mohamad Amin Pourhoseingholi, Mehdi Azizmohammad Looha, Saba Ilkhani, Hamidreza Hatamabadi, Amir Sadeghi, Seyed Amir Ahmad Safavi-Naini, Kamran Heidari, Nazanin Taraghikhah, Mohammad Mahdi Fallah, Reyhaneh Kalantar, Nariman Naderi, Romina Esbati, Nastaran Ebrahimi, Ali Solhpour, Tannaz Jamialahmadi, Amirhossein Sahebkar   +15 more
doaj